Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Compass Therapeutics, Inc.

NASDAQ: CMPX · Life Sciences · 3 alerts · CIK 1738021

Share price
$0.6615Close, Nov 16
Market cap
$119M
Shares outstanding
180.09MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Compass Therapeutics, Inc. filings on SEC EDGAR ↗

8:32 AM ET 8-K
Court & Legal Update

Compass Therapeutics Court & Legal Update

Compass Therapeutics received regulatory feedback from the FDA recommending a new clinical trial to demonstrate survival benefit before submitting a Biologics License Application (BLA) for tovecimig in biliary tract cancer. The company disagrees with the recommendation, citing statistically significant improvements in objective response rate and progression-free survival from its Phase 2/3 COMPANION-002 study. Compass intends to further engage with the FDA to determine the path forward for its planned BLA submission.

Counterparty
FDA

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.